We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Global Skin-Ulcer Treatment Market to Grow

By HospiMedica staff writers
Posted on 18 Sep 2007
The market for skin ulcer treatments will see solid growth over the next four years due to demographic shifts and new treatments such as negative wound pressure therapy, sending the market to US$6.2 billion in 2011, according to a new report.

Overall steady growth in the worldwide skin ulcer treatment market will likely come from new therapies that result in decreasing healing times and subsequent cost savings; a growing focus on special populations such as diabetics and the obese; an increasing elderly population; availability of new therapeutic techniques; and the recent focus on wound care products and prevention, according to a new report by Kalorama Information (New York, NY, USA). More...


Mature skin treatment products such as anti-infectives, skin ulcer management, and pressure relief devices will continue to generate the majority of sales, but advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. Additionally, negative pressure wound therapy--the use of vacuum pressure within a foam sponge and adhesive wrap, which stimulates blood flow and promotes faster healing--is a segment expected to boost market sales with another dose of significant growth, estimated at 11.6%.

"Developments in treatments of skin ulcers have made tremendous strides in the last decade,” said report author analyst Mary Anne Crandall. "New developments are providing the health care arena of today with some truly sophisticated, highly effective skin ulcer treatments. Revolutionary advances using tissue engineering, growth factors, animal-fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience acute and chronic skin ulcers.”

Kalorama Information is a company that provides market research reports for pharmaceuticals, medical devices, diagnostics, biotechnology, and healthcare


Related Links:
Kalorama Information

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Spirometry & Oximetry Software
MIR Spiro
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.